Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03064711
Other study ID # Tali- HMO-CTIL
Secondary ID
Status Completed
Phase N/A
First received February 22, 2017
Last updated February 22, 2017
Start date January 2013
Est. completion date January 2016

Study information

Verified date February 2017
Source Hadassah Medical Organization
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Early diagnosis of respiratory impairment in Post-Polio (PPS) patients may delay respiratory decline and future need of invasive respiratory aids.

Objectives: To compare pulmonary function measures, maximal respiratory pressure and activity levels and fatigue of respiratory muscles between patients with PPS and healthy controls.

Design: Cross-sectional study. Setting: Hadassah physical medicine and rehabilitation department, Jerusalem. Patients: Patients with PPS (N=12; 6 males; age 62.1±11.6 years) able to walk for 6 minutes without human assistance; age-matched healthy subjects (N=12; 4 males; age 62.2±6.5 years).

Intervention: None. Measurements: A body plethysmograph was used to quantify forced expiratory volume in the first second of a forced expiratory maneuver, vital capacity, slow vital capacity, Residual Volume (RV), Total Lung Capacity (TLC), and Thoracic Gas Volume (TGV). Also, RV to TLC ratio is calculated. A manometer was used to measure Maximal Inspiratory Pressure (MIP) and Maximal Expiratory Pressure (MEP). A spirometer was used to measure Maximal Voluntary Ventilation (MVV). Surface electromyography (sEMG) recorded diaphragmatic muscle activity during rest and while performing MVV.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date January 2016
Est. primary completion date January 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Diagnosed with post-polio syndrome

- Able to walk for 6 minutes, with or without walking aids and orthotics but without human assistance

Exclusion Criteria:

- Any neurological or orthopedic condition, unrelated to post-polio syndrome

Study Design


Intervention

Diagnostic Test:
Electronyugraphy
Surface electromyography (sEMG) recorded diaphragmatic muscle activity during rest and while performing maximal voluntary ventilation

Locations

Country Name City State
Israel Hadassah Medical Center Jerusalem

Sponsors (1)

Lead Sponsor Collaborator
Hadassah Medical Organization

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Median frequency of electromyography measure related to fatigue measured during maximal voluntary ventilation Two hours
Secondary Pulmonary function Measured using a body plethysmograph Two hours
Secondary maximal inspiratory/expiratory pressures Measured using ahand-held portable, digital manometer Two hours
See also
  Status Clinical Trial Phase
Terminated NCT02176863 - Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome Phase 2/Phase 3
Active, not recruiting NCT03561623 - Spinal Cord Gray Matter Imaging in Post Polio Syndrome
Completed NCT02815878 - Enhance Wellness for Individuals With Long-Term Physical Disabilities N/A
Recruiting NCT05644522 - Nomad P-KAFO Study N/A
Completed NCT02801071 - L-Citrulline in Patients With Post-Polio Syndrome Phase 3
Completed NCT01537575 - Intravenous Immunoglobulins for Post-Polio Syndrome Phase 3
Active, not recruiting NCT02089880 - Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis N/A
Completed NCT01402570 - Glutathione and Health With Post-Polio Syndrome N/A
Completed NCT00231439 - Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg) Phase 2/Phase 3